Skip to main content
Download PDF

Trends in immunological markers of transfusion transmissible infections among blood donors in Mamfe District Hospital, Southwest Cameroon

BMC Infectious Diseases volume 24, Article number: 370 (2024) Cite this article

Abstract

Background

Blood transfusion is associated with exposure to blood Transfusion Transmissible Infection (TTIs). The threat posed by the blood-borne pathogens is disproportionately distributed in different healthcare facilities in Cameroon. Thus, there is a need for continuous surveillance of TTIs in the country. This study aimed to assess the screening procedure for blood transfusion and determine the trend in immunological markers of TTIs among blood donors at the Mamfe District Hospital.

Methods

A prospective descriptive, cross-sectional and analytical study was conducted at Mamfe District Hospital from March to May 2022. A total of 165 blood donors were recruited by the consecutive sampling method. Donors were screened using both Rapid diagnostic tests,T. pallidum haemagglutination test and indirect enzyme-linked immunosorbent assay (ELISA) for the detection of TTIs. Data generated was entered into an Excel spreadsheet and analysed using the statistical software R, version 4.2.0. Statistical analysis included descriptive statistics of percentages, means ± standard deviation, and student t-test was used to compare both diagnostic techniques, and was considered significant when p < 0.05.

Results

A hundred and sixty-five donors were enrolled in the study with a male preponderance giving a male-female sex ratio of 22.5 and a mean age of 32.23 ± 8.60 years. The majority (75.2%) of the donors were of the O-positive blood type, repeat donors (69.1%) and were mainly family replacement and paid donors as against the voluntary blood donors (39.4% and 37.0% vs. 23.6% respectively). overall TTIs prevalence was 18.78% (31/165) (), with HBsAg being the most predominant marker at 12.12% (20/165) followed by Treponema pallidum, HCV and HIV antibodies at 4.85 (8/165), 1.21%(2/165), 0.60% (1/165) respectively. Except for the HBV, The prevalence of TTIs was higher when using a single RDT than the ELISA test, and the difference was significant (p < 0.05).

Conclusion

Bloodborne pathogens remain a major menace to safe blood transfusion practice in Mamfe district hospital and their detection could be easily missed if the RDT method alone is used for donor screening. Therefore, the donor screening protocol in Mamfe District Hospital should systematically incorporate a confirmation diagnostic test such as ELISA.

Peer Review reports

Background

Blood transfusion is an integral and life-saving procedure of modern medical science since the discovery of human whole blood transfusion in 1818 by Dr. James Blundell [1]. It remains an important therapeutic option in many of the life-threatening diseases and also in sustaining life after severe blood loss.

In high-income countries like the United States and many European countries, due to continuous implementation and improvement of more sensitive serologic methods and nucleic acid amplification test (NAT), the residual risk of TTI transmission decreased in 2000 to less than 1: 250,000 for hepatitis C virus (HCV) and 1: 1.3 M for HIV [1, 3]. This however contrasts the findings in many low and middle-income countries (LMICs) where TTIs appear to be more prevalent [2, 3, 4].

Unreliable supply of test kits, and lack of capacity building of laboratory personnel and infrastructures can be some of the factors which could have led to this issue [5, 6].

Furthermore, the majority of blood donors in SSA are either family replacement donors or paid donors [7]. Several documented evidence have shown that blood from these donors are relatively unsafe and less free from TTIs when compared with those from voluntary non-remunerated donors (VNRD) [8, 9]. The VNRD are the recommended blood donors by World Health Organization (WHO) and they form a significant proportion of blood donors in developed countries [7].

In Cameroon, like many other countries in SSA, blood transfusion services are still largely hospital-based, thus the prevalence of TTIs varies depending on the geographical location and sophistication of transfusion practices in that hospital or district. A study in an urban hospital in Douala reported that 13.7% of the tested donors were positive for at least one of the TTIs [Human immunodeficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV) and Syphilis]. Amongst the infected participants, 8.3% were voluntary donors while 14.3% were family replacement donors [10]. A similar study at the Bamenda hospital-based blood services reported a seroprevalence rate of 10.5% for the four conventional TTIs markers [11]. Studies from other SSA countries with similar demographics have reported similar findings in Kenya, Nigeria and Ethiopia [12,13,14,15].

Transfusion of unsafe blood poses a health challenge not only to the recipients but also to the larger society as it adds to the cost of healthcare. Therefore, continuous evaluation of the burden of TTIs among blood donors will help generate evidence-based data upon which protocol for enhancing donor selection strategies and blood safety surveillance systems can be established. Therefore, the objectives of this study were to unveil the demographic profile of blood donors and; determine the trends in immunological markers of TTIs at the Mamfe district hospitalin the South West region of Cameroon.

Methods

Study site

This study was carried out at Mamfe District Hospital (MDH), which has an hospital-based blood bank. MDH is a public institution situated at latitude: 5°45’4.12’’N and longitude: 9°18’5.5’’E in the Mamfe subdivision, Manyu division, South West region of Cameroon. It serves as a referral hospital to 14 functional satellite health centres within the Manyu division, located along the Besong Abang-Ekok highway, the trans-African highway truck 6 bordering the Federal Republic of Nigeria.

Study design

This was a prospective cross-sectional, descriptive and analytical study designed to achieve the set objectives of the study.

Study period

Blood samples of all consented prospective blood donors recruited at the MDH between March to May 2022 were used for this study.

Study population

These were prospective blood donors recruited at the hospital-based blood bank of MDH between March and May 2022.

Study criteria

Inclusion criteria

Prospective blood donors had to meet the following conditions: between 18 and 60 year of age, weighing at least 50 kg, presenting at the MDH for blood donation; More over, the medical history of these participants had to fit the requirements of WHO guidelines on assessing donor suitability for donation [16] and National Blood Transfusion Service protocol [17]. All participants had to provide written consent before recruitment.

Exclusion criteria

Potential donors were excluded if they donated blood on an interval less than 3 months, were anaemic, had a history of jaundice, malaria, asthma, high-risk (have had unsafe intercourse, drug abuse, tattooing), had history of HBV, HCV, HIV infection.

Sampling method and donor recruitment

The participants were consecutively recruited into the study within the study period (March–May 2022). Before the participants were recruited for the study, a community sensitization campaign was carried out within the Mamfe region and its environs on the therapeutic importance of blood transfusion and the benefits of blood donation to the donors via the local radio station in the subdivision. Also, health talks on healthy living for blood donors were organized at the MDH waiting hall for all prospective donors. All participants who met the inclusion criteria were enrolled in the study.

Screening procedure

The National blood transfusion service (NBTS)-TTI recommended screening algorithm (Fig. 1) was used for the following assays: Hepatitis-B surface antigen (HBsAg), Enzyme Linked Immunosorbent Assay (ELISA) anti-Hepatitis-C virus antibodies (anti HCV) and HIV antibody-ELISA 4.0 fourth generation, Treponema Pallidum Hemagglutination Assay (TPHA) and Malaria parasite rapid diagnostic test (RDT).

Fig. 1
figure 1

National blood transfusion service (NBTS)-TTI recommended screening algorithm [17]

Full size image

About 5 mls of whole blood was collected by venipuncture from all consenting eligible blood donors into plain dry tubes (Sarstedt, Nümbrecht, Germany) under aseptic conditions. The tubes were centrifuged at 3500 rpm for 5 min after which serum was separated, then transferred into an Eppendorf tube labelled with a unique identification number assigned to that participant and stored in a refrigerator at − 200C. Each sample was stored in duplicate. The stored serum was tested across the RTD and ELISA simultaneously for the detection of HBsAg, HIV antibody, anti HCV and Treponama pallidum pallidum antibody (Biolabo®).

For HIV, we used the Alere Determineâ„¢ HIV-1/2. For HBsAg and HCV antibodies we used Fortress HBs Ag for the direct ELISA test and Fortress HCV for the indirect ELISA test. All the procedure was done and cut off values determined following the instructions of the manufacturers. The overall prevalence of TTIs was calculated as the number of TTIs positive donors to the total number of donors in the study.

Data analysis

Data was collected, entered into an Excel spreadsheet and analysed using the statistical software R version 4.2.0 [18]. Statistical analysis included descriptive statistics of percentages, means ± standard deviation; t-test and chi-square difference was considered significant at p < 0.05.

Ethical consideration

All participants were fully informed about the study and only those who provided written consent were recruited. The protocol was approved by the Cameroon National Ethical Committee for research on Human Health before the commencement of the study.

Results

Description of socio-demographic characteristics of the study population

A total of 165 eligible blood donors were enrolled in this study: 95% males while a little less than 5% were females. The predominant age group among the donors were those between the age brackets of 18–33 years (56.4%). Many (25.5%) of the donors were farmers, while the least represented occupations were accountants and teachers (4%, and 5%) respectively. In addition, more than half of the donors (54.6%) were unmarried (Table 1).

Table 1 Socio-demographic characteristics of the study population
Full size table

ABO Blood group distribution and donor characteristics

A significant proportion (75.2%) of the blood donors were of the Rh O + blood type. The remaining (25%) comprise the other blood types in descending order of occurrence (A+-15% >B+- 13%). None of the donors were of the AB blood type. Also, the majority (39.4%) of the donors were family replacement donors while 37.0% were paid donors. Voluntary non-remunerated donors were the least represented (23.6%). In addition, the majority of the donors were first-time donors (30.9%) (Table 2).

Table 2 ABO blood group distribution and donor characteristics
Full size table

Overall seroprevalence of TTIs using ELISA

The overall seroprevalence of TTIs in the study population was 17.6%(29/165) using ELISA testing (Fig. 2). Unfit donors with at least one infection was 18.18% (30/165) (amongst which 29 single in infections and 1 co-infection); while 81.81% (135/165) qualified as Fit donors who tested negative for both RDTs and ELISA screening.

Fig. 2
figure 2

Prevalence of TTIs in the study population

Full size image

The seroprevalence of TTIs were 9.7%and 12.1% for HBSAg, 6.1% and 4.8% for Treponema pallidum, 6.7% and 1.2% for HCV antibodies, 2.4% and 0.6% for HIV antibodies; respectively with RDTs and ELISA (Table 3). The most prevalent TTI using both techniques was HBV.

Table 3 Comparing the immunological markers of TTIs between RDT vs. ELISA Techniques
Full size table

Discussion

Many countries in Sub-Saharan Africa including Cameroon are faced with the challenge of blood safety and availability due to the relatively high prevalence of blood-borne viruses and other infectious diseases prevalent in the region. Therefore, continuous monitoring of the TTIs among the donor population using confirmatory tests is an important index for measuring the effectiveness of existing interventions for better and appropriate control measures.

The preponderance of donors in this study were males and more than 50% were within the age bracket of 18–33 years. A similar pattern has been reported in other regions within Cameroon and indeed other regions in SSA. A six-year review of blood donors at Bamenda regional hospital-based blood bank in Cameroon reported a male donor population of over 85% with 52% being between the ages of 20–29 years [11]. In a similar study, Eboumbou et al. [10] reported a male-to-female ratio of 4:1 among their donor population with the majority of the donors in their third decade of life [10]. In addition, studies in other regions in sub-Saharan Africa have reported similar demographic characteristics among their donor populations [15, 19].

The World Health Assembly resolution WHA63 urges all member states to develop national blood systems based on voluntary unpaid donors. However, in many countries in SSA, family replacement donors (FRD) and paid donors still form a significant pool of their donor population [3]. This finding was corroborated in this study and consistent with studies by Eboumbou et al. [10] and authors in Nigeria, Ghana, and Ethiopia. However, the estimates of FRD in these other studies were much higher than in our study. (89.1%, 96.3% and 88% respectively) [20,21,22]. Reliance on FRD as a major source of blood supply may affect the timely availability of blood especially in emergency situationswhere family or relatives are not available to donate. Furthermore, blood from paid donors is known to be a major source of TTIs [7, 23].

A major challenge in transfusion practice is donor retention. Lack of repeat donors may impede blood collection and consequently incapacitate the blood transfusion service in maintaining a constant supply of blood. However, in this study, the repeat donors cumulatively were more than the first-time donors. This finding is consistent with the studies by Suemnig et al., [24] and Mauka et al. [25]. In these studies, aimed at determining the factors associated with repeat blood donations by eligible blood donors, the authors reported a donor population of 85.3% vs. 14.3% and 63.9% vs. 36.1% for repeat donors and first-time donors respectively. However, it contrasts with the study by Mohammed et al., [26] who reported more first-time donors than repeat donors (54.9% vs. 45.1%).

Several factors have been suggested as responsible for a donor returning for further donation including altruistic behaviour of the donor, convenient environment and pleasant donation experience, knowledge concerning blood donation and receiving remuneration among others. A combination of these factors may be responsible for the donor behaviour in this study given that there is significant representation of the various types of blood donors reported here.

The overall prevalence of the TTIs in the study was 17.6%. This was slightly higher than the values from similar studies in the littoral region (13.7%) and North West 55555555555 region (10.5%) of Cameroon respectively [10, 11]. It was also slightly higher than the values from studies in Ethiopia (12.4%) [19], Kenya (12%) [27], and Nigeria (13%) [28]. However, it was comparable to studies from Mozambique (18.7%) [29], and Ghana (18.3%) [30], but lower than the values in studies from Wolaita Sodo, Ethiopia (29.5%) [21], Equatorial Guinea (47.4%) [31], and Edea, Cameroon (21.2%) [32].

Several factors may account for these differences in prevalence of these TTIs including differences in the population risk which differ from one country to another and even regions within the same country. Also, the donor recruitment strategies may differ from one country or region to another. Furthermore, the sensitivity and specificity of the various assay techniques used for the detection of the various TTIs may also account for the differences in the prevalence of these infections.

When assessed individually, the prevalence of each of the TTIs using the RDT screening method was relatively higher (HCV-6%, HIV-2.4%, Syphilis-6.1%) than with the ELISA screening technique (HCV-1.2%, HIV-0.6%, Syphilis-4.8%) except for HBV. The ELISA screening technique is widely used in many blood banks as the assay of choice as they are well suited to screening from relatively small to large numbers of samples. Also, they have a higher sensitivity and specificity and are superior to RDT in testing blood donors for TTIs. Furthermore, the ELISA test has a higher positive and negative predictive value and fewer cases of false negative results [8, 33].

Also, from both screening methods (RDT vs. ELISA) HBV infection was the most prevalent TTIs recorded amongst the donors (9.7% and 12.1%). These values are similar to those of some earlier studies in Cameroon. Noubiap et al. [32] reported HBV prevalence of 10.7% among first-time blood donors in Edea, while Sama et al. [34] in a similar study, reported HBV prevalence of 10.1%. Perhaps, the endemicity of this viral infection in sub-Saharan Africa may account for this relatively high prevalence observed in various studies. The overall carrier rate in the general population in this region is 9–20%, and this has been reported to be among the highest globally [35].

The prevalence of HCV in this study was 1.2% and 6.7% using the ELISA and RDT techniques respectively. The trends in this infection among donors vary. While some studies reported a relatively low prevalence others reported otherwise. A study among blood donors in Bamenda Hospital blood service in the Northwest region of Cameroon reported a prevalence of 1.7%, and 1.35% among donors in Laquintinie Hospital in Douala. A similar finding was reported by Macky et al. in Tanzania and Motayo et al. in Southwest Nigeria. On the other hand, Noubiap et al. [31] in Cameroon reported a slightly higher prevalence of 4.2%; and 8.0% infection rate was reported by Bartonjo et al. [12] in Kenya and 3.6% by Okoroiwu et al. [20] in Nigeria. The differences observed in the different studies may be due largely to the assay methodology employed in the detection of the HCV in the donor’s sample as well as the endemic nature of this infection in the locality.

The prevalence of HIV among the donors in this study was 0.6% and 2.4% (ELISA vs. RDT). This value is much less than the population average of 3.7% of adults living with HIV in Cameroon [36]. A similar low prevalence of 1.7% was reported by Eboumbou et al., among blood donors in a hospital blood bank in Douala. However, this contrasts with studies from other regions in Cameroon in which a relatively higher prevalence of 2.2%, 4.1% and 7.5% were reported perhaps due to the use of the RDT method in screening of donors in these studies [11, 31, 38]. The low prevalence rate may be attributed to the robust awareness and sensitization program on HIV/AIDS prevention and control in the region where this study was conducted. These awareness and intervention programs are known to have contributed significantly to the reduction or decline in HIV infection in SSA [37].

Although primarily transmitted through sexual contact, syphilis may also be transmitted via transfusion of blood and blood components donated by asymptomatic donors harbouring the infection and remains a significant threat to safe transfusion practice in many Sub-Saharan countries. The prevalence of 6.1% and 4.8% reported from the use of RDT and TPHA respectively in this study is somewhat worrisome. Earlier studies in Cameroon have reported values similar to the above prevalence [10, 31, 39]. However, the trends from recent studies have reported significantly lesser values: Guekeng et al. [40] 2.31%; Samje et al. [11] reported a prevalence of 2.2%, while a prevalence of 3% was reported among donors in Douala. The relatively high prevalence observed in this study may be due to reduced attention being paid to the disease compared to HIV infection. In addition, paid donors constitute more than 35% of donors in this study. This group of blood donors are known to be high-risk donors with a high potential for harbouring any of the TTIs [23].

Compared to other similar studies, the relatively low sample size in this study constitutes a limitation. This may be attributed to the short duration of the study. Also, responses from the donors could not be verified.

Conclusion

Transfusion transmissible infections still pose a major health challenge to safe blood transfusion in Mamfe District Hospital given the relatively high prevalence of viral immunological markers detected duly largely to the donor screening method (RDT) adopted. Therefore, we recommend the use of ELISA as the minimum screening method for all donor units in the centre.

Data availability

All data generated and analysed in this study are as presented in the result section of the study. Data pertaining to participants personal information are archieved in the hospital blood bank.

Abbreviations

MDH:

Mamfe District Hospital

NBTS:

National blood transfusion service

TTIs:

Transfusion transmissible infections

SSA:

Sub-saharan Africa

VNRD:

Voluntary Non-Remunerated Donors

References

  1. Velati C, Romano L, Fomiatti L, Baruffi L, Zanetti AR. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008;48:2205–13. https://doi.org/10.1111/j.1537-2995.2008.01813.x.

    Article  PubMed  Google Scholar 

  2. Tagny CT, Kouao MD, Touré H, Gargouri J, Fazul AS.Ouattara S.,…, Lefrère JJ. Transfusion safety in francophone African countries: an analysis of strategies for the medical selection of blood donors. Transfusion. 2012;52(1):134–43. https://doi.org/10.1111/j.1537-2995.2011.03391.x

  3. World Health Organization (WHO). Global database on blood safety. Geneva, Switzerland. Available online: http//www.who.int/bloodsafety/globaldatabase/GDBS summary report 2011. [Accessed in 22nd July 2022].

  4. Ifland L, Bloch EM, Pitman JP. Funding blood safety in the 21st century. Transfusion. 2018;58(1):105–12. Pmid: 29030857.

    Article  PubMed  Google Scholar 

  5. Sachdev S, Mittal K, Patidar G, Marwaha N, Sharma RR, Duseja AK, et al. Risk factors for Transfusion Transmissible Infections Elicited on Post Donation Counselling in Blood donors: need to strengthen pre-donation counselling. Indian J Hematol Blood Transfus. 2015;31(3):378–84.

    Article  PubMed  Google Scholar 

  6. Biadgo B, Shiferaw E, Woldu B, Alene KA, Melku M. Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: a three years’ retrospective study. PLoS ONE. 2017;12(7):e0180416.

    Article  PubMed  PubMed Central  Google Scholar 

  7. WHO. Blood safety Factsheets. Available online: http//www.afro.who.int. 2022 [Accessed in 15th January 2023].

  8. Abdel MIY, Ismail MA, Saad AA, Azer MR. The degree of safety of family replacement donors versus voluntary non-remunerated donors in an Egyptian population: a comparative study. Blood Transfus. 2014;12(2):159–65.

    Google Scholar 

  9. Addai-Mensah O, Bashiru PA, Dogbe EE. Safety of family replacement donors’ vs voluntary non-remunerated donors in Komfo Anokye Teaching Hospital, Ghana: a comparative study. J Med Biomedical Sci. 2015;4(1):11–6.

    Article  Google Scholar 

  10. Eboumbou MCE, Ngo SF, Essangui SEG. HBV, HCV and T. Pallidum infections among blood donors and transfusion-related complications among recipients at the Laquintinie hospital in Douala, Cameroon. BMC Hematol. 2014;14:5. https://doi.org/10.1186/2052-1839-14-5. Mbangue M, Lehman LG. HIV.

    Article  Google Scholar 

  11. Samje M, Fondoh VN, Nguefack-Tsague G, Kamalieuk LKJ, Mbanya D, Murphy EL, Tagny CT. Trends in serological markers of transfusion transmissible infections in blood donations at the Bamenda Hospital-based Blood Service, Cameroon. Transfus Clin Biol. 2021;28(3):228–33.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Bartonjo G, Oundo J, Ng’ang’a Z, Mwangi J. Prevalence and associated risk factors of transfusion transmissible infections among blood donors at Regional Blood Transfusion Center Nakuru and Tenwek Mission Hospital, Kenya. PAMJ. 2019;34:31. https://doi.org/10.11604/pamj.2019.34.31.17885.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ogbenna A, Adewoyin SA, Famuyiwa CO, Oyewole KM, Oyedeji OA, Akanmu AS. Pattern of blood donation and transfusion transmissible infections in a hospital-based blood transfusion service in Lagos, Nigeria. West Afr J Med. 2021;38(11):1088–94.

    Article  Google Scholar 

  14. Ataro Z, Urgessa F, Wasihun T. Prevalence and Trends of Major Transfusion Transmissible Infections among blood donors in dire Dawa Blood bank, Eastern Ethiopia: Retrospective Study. Ethiop J Health Sci. 2018;28(6):701–10. https://doi.org/10.4314/ejhs.v28i6.4.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ekwere TA, Ino-Ekanem M, Motilewa OO. Iquo Augustine Ibanga. Pattern of blood donor deferral in a tertiary hospital, South-South Nigeria: a three-year study review. Int J Blood Transfus Immunohematol. 2014;4:7–13.

    Google Scholar 

  16. World Health Organization. (2012). Blood donor selection: guidelines on assessing donor suitability for blood donation.

  17. Ministry of public health (Cameroon). Guideline on the relationship between the National Blood Transfusion Program and Associations Using for the Promotion of Blood Donation. 2017.

  18. https://www.r-project.org. [Accessed in 15th January 2023].

  19. Heyredin I, Mengistie B, Weldegebreal F. Sero-prevalence of transfusion-transmittable infections and associated factors among blood donors in Eastern Ethiopia: an institutional-based cross-sectional study. SAGE Open Med. 2019;7:2050312119834468. https://doi.org/10.1177/2050312119834468.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, Syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645. https://doi.org/10.1186/s12889-018-5555-x.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ampofo W, Nii-trebi N, Ansah J, Abe K, Naito H, Aidoo S, et al. Prevalence of blood-borne infectious diseases in Blood donors in Ghana. J Clin Microbiol. 2002;40(9):3523–5.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Bisetegen FS, Bekele FB, Ageru TA, Wada FW. Transfusion-Transmissible Infections among Voluntary Blood Donors at Wolaita Sodo University Teaching Referral Hospital, South Ethiopia. Can J Infect Dis Med Microbiol. 2016; 2016:8254343 https://doi.org/10.1155/2016/8254343.

  23. Nwogoh B, Ikpomwen OD, Isoa EM. Donor blood procurement and the risk of transfusion transmissible viral infections in a tertiary health facility in South-South Nigeria. Niger Med J. 2011;52(4):227–9. https://doi.org/10.4103/0300-1652.93793. PMID: 22529503; PMCID: PMC3329090.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Suemnig A, Konerding U, Hron G, Lubenow N, Alpen U, Hoffmann W, Kohlmann T, Greinacher A. Motivational factors for blood donation in first-time donors and repeat donors: a cross-sectional study in West Pomerania. Transfus Med. 2017;27(6):413–20. https://doi.org/10.1111/tme.12450. Epub 2017 Aug 7. PMID: 28786224.

    Article  CAS  PubMed  Google Scholar 

  25. Mauka WI, Mahande MJ, Msuya SE, Philemon RN. Factors Associated with Repeat Blood Donation at the Northern Zone Blood Transfusion Centre in Tanzania. J Blood Transfus. 2015;2015:717653. https://doi.org/10.1155/2015/717653. Epub 2015 Dec 13. PMID.

  26. Mohammed S, Essel HB. Motivational factors for blood donation, potential barriers, and knowledge about blood donation in first-time and repeat blood donors. BMC Hematol. 2018;18:36. https://doi.org/10.1186/s12878-018-0130-3.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Wairimu K, Herbert K, John M. Prevalence of transfusion transmissible infections among blood donated at Nyeri Satellite transfusion centre in Kenya. IOSR J Pharm. 2016;6:20–30.

    Google Scholar 

  28. Ajugwo A, Erhabor T, Eledo B, Eze R, Digban K. Prevalence of transfusion transmissible infections in a Nigerian tertiary hospital. J Transmit Dis Immun. 2017;1(2):32–4.

    Google Scholar 

  29. Stok J, Gillet P, Weggheleire A, et al. Sero-prevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique. BMC Infect Dis. 2011;11:141.

    Article  Google Scholar 

  30. Adu-poku F, Agboli E, Tarkang EE. Seroprevalence of transfusion-transmissible infections among blood donors in the Hohoe Municipality Hospital, Ghana: 2015–2016: a retrospective hospital-based cross-sectional study. PAMJ Clin Med. 2020;2:12. https://doi.org/10.11604/pamj-cm.2020.2.12.20658.

    Article  Google Scholar 

  31. Xie DD, Li J, Chen J, et al. Sero-prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and Treponema pallidum infections among blood donors on Bioko Island, Equatorial Guinea. PLoS ONE. 2015;10(10):e0139947.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Noubiap JJN, Joko WYA, Nansseu JRN, Tene UG, Siaka C. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Int J Infect Dis. 2013;17(10):e832–7.

    Article  PubMed  Google Scholar 

  33. WHO. Screening of donated blood for Transfusion transmissible infections: recommendations. Available online: www.who.int/publications-detail-redirect/9789241547888. [Accessed in 13 th May 2022].

  34. Monny Lobe SM, Ndjitoyap Ndam M. Prevalence of transfusion transmitted infectious agents among healthy blood donors in Cameroon. Int Conf AIDS. 2004;16:15–20.

    Google Scholar 

  35. Kiire CF. The epidemiology and prophylaxis of hepatitis B in sub-saharan Africa: a view from tropical and subtropical Africa. Gut. 1996;38(Suppl 2):5–12. https://doi.org/10.1136/gut.38.suppl_2.s5. PMID: 8786055; PMCID: PMC1398049.

    Article  Google Scholar 

  36. 2017–2018 Cameroon Population-based HIV impact assessment. Available from: https://phia.icap.columbia.edu/countries/cameroon. [Accessed in 10 th May 2022].

  37. National Research Council (US) Panel on Data and Research Priorities for Arresting AIDS in Sub-Saharan Africa; Cohen B, Trussell J, editors. Preventing and Mitigating AIDS in Sub-Saharan Africa: Research and Data Priorities for the Social and Behavioral Sciences. Washington (DC): National Academies Press (US). 1996. Summary. Available from: https://www.ncbi.nlm.nih.gov/books/NBK232817/. [Accessed in 10 th April 2022].

  38. Mbanya DN, Takam D, Ndumbe PM. Serological findings amongst first-time blood donors in Yaoundé, Cameroon: is safe donation a reality or a myth? Transfus Med. 2003;13:267–73. https://doi.org/10.1046/j.1365-3148.2003.00453.x.

    Article  CAS  PubMed  Google Scholar 

  39. Saki MC, Ayangma CR, Voundi VE, Ndoumba AM, Ngogang MP, Eyoum BB. Evaluation of risk of transfusion transmissible infections in blood donors at the Laquintinie hospital in Douala. J Adv Res Med Health Sci. 2022;8(5):20–7. https://doi.org/10.53555/nnmhs.v8i5.1289.

    Article  Google Scholar 

  40. Dongmo EG, Nsagha DS, Zofou D, Njunda AL, Joseph A. Residual risk of HIV transmission through blood transfusion in five blood banks in Cameroon. J Med Res. 2020;6(4):158–65.

    Article  Google Scholar 

Download references

Acknowledgements

Medecins sans frontiers (MSF) in supply of some equipments and power or energy supply.

Funding

This research was funded by the authors.

Author information

Authors and Affiliations

  1. Department of Microbiology, Immunology and Hematology, Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon

    Sen Claudine Henriette Ngomtcho, Olive Njike Ngo Biyong, Sandra Maella Makamdoum Bogne, Omer Aurelle Nkengkanna & Henri Lucien Fouamno Kamga

  2. Molecular biology and serology units, National Public Health Laboratory, Ministry of Public Health , Yaoundé, Cameroon

    Sen Claudine Henriette Ngomtcho

  3. Mamfe District Hospital, Mamfe, Cameroon

    Olive Njike Ngo Biyong & Henrietta Mbah

  4. Department of Haematology, University of Uyo/University of Uyo Teaching Hospital, Uyo, Akwa Ibom State, Nigeria

    Timothy Amos Ekwere

  5. Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, Buea, Cameroon

    Jonas Merlin Wandji Takemegni

  6. Department of Medical Laboratories Sciences, New-bell District Hospital, Douala, Cameroon

    Jonas Merlin Wandji Takemegni

Authors
  1. Sen Claudine Henriette Ngomtcho
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Olive Njike Ngo Biyong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy Amos Ekwere
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonas Merlin Wandji Takemegni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Henrietta Mbah
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sandra Maella Makamdoum Bogne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Omer Aurelle Nkengkanna
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Henri Lucien Fouamno Kamga
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SCHN designed the study, supervised laboratory experiments, analysed data, drafted and wrote the manuscript. ONBN designed the study, performed laboratory experiments, analysed data, wrote the manuscript. TAE analysed data and wrote the manuscript MJWT, OAN and MSMB edited the manuscript. MH conducted the semi-medical screening of donors. HLK contributed in study design and edited the manuscript.All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sen Claudine Henriette Ngomtcho.

Ethics declarations

Ethics approval and consent to participate

Before enrollment, prospective donors were informed of the purpose and process of the investigation (goals, methodology, study constraints, data confidentiality, and rights to opt-out from the study), and written informed consent was obtained from all participants. Standard questionnaires and data collection sheets were used to collect anthropometric, demographic socio-demographic, clinical, and biological data. This study was conducted in accordance with ethics that govern research on humans in Cameroon. Authorization and approval letters were obtained from the Mamfe District Hospital and the Mamfe health service before the commencement of this study. An ethical clearance was obtained from the office of the National Ethics Committee of Cameroon.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ngomtcho, S.C.H., Njike Ngo Biyong, O., Ekwere, T.A. et al. Trends in immunological markers of transfusion transmissible infections among blood donors in Mamfe District Hospital, Southwest Cameroon. BMC Infect Dis 24, 370 (2024). https://doi.org/10.1186/s12879-024-09119-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12879-024-09119-0

Keywords

BMC Infectious Diseases

ISSN: 1471-2334

Contact us